Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

Nine Months Ended

October 1,

 2022

October 2,
2021

Operating Activities

Net income

$     66,041

$2,120,497

Adjustments to reconcile net income to net cash provided by operating activities

   of continuing operations:

   Income from discontinued operations, net of income taxes

--

(2,183,884)

   Depreciation of property and equipment

16,514

12,925

   Amortization of other intangible assets

27,328

33,971

   Amortization of debt discount and debt issuance costs

1,492

17,278

   Loss on extinguishment of convertible debt

3

3,370

   Stock-based compensation expense

43,213

36,916

   Equity-method earnings

(2,985)

(5,938)

   Deferred income taxes

(13,126)

(3,132)

   Changes in operating assets and liabilities:

      Accounts receivable

21,641

22,573

      Inventories

(39,100)

(11,320)

      Prepaid expenses and other assets

(28,404)

33,536

      Accounts payable

26,694

(4,522)

      Other current liabilities and income taxes

17,962

(10,981)

      Deferred revenue and returns liability

(2,144)

(1,657)

      Other non-current liabilities

(7,713)

(11,388)

Net cash provided by operating activities of continuing operations

127,416

48,244

Investing Activities

Purchases of marketable securities

(579,507)

(1,212,572)

Sales of marketable securities

42,952

194,492

Maturities of marketable securities

597,399

173,924

Purchases of property and equipment

(20,057)

(19,468)

Purchases of other assets

--

(578)

Net cash provided by (used in) investing activities of continuing operations

40,787

(864,202)

Financing Activities

Payments on debt

(21)

(140,572)

Repurchases of common stock

(681,695)

(688,373)

Payment of taxes withheld for vested stock awards

(14,732)

(21,393)

Proceeds from the issuance of common stock

6,366

8,619

Net cash used in financing activities of continuing operations

(690,082)

(841,719)

Discontinued Operations

Operating activities

(69,467)

69,685

Investing activities

--

2,747,684

Net cash provided by (used in) discontinued operations

(69,467)

2,817,369

Increase (decrease) in cash and cash equivalents

(591,346)

1,159,692

Cash and cash equivalents at beginning of period

1,074,623

202,720

Cash and cash equivalents at end of period

$   483,277

$1,362,412